Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Change in Cash (2017 - 2022)

Historic Change in Cash for Iterum Therapeutics (ITRM) over the last 6 years, with Q4 2022 value amounting to $573000.0.

  • Iterum Therapeutics' Change in Cash rose 10671.27% to $573000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was -$6.4 million, marking a year-over-year decrease of 15029.15%. This contributed to the annual value of $18.1 million for FY2024, which is 22019.17% up from last year.
  • Per Iterum Therapeutics' latest filing, its Change in Cash stood at $573000.0 for Q4 2022, which was up 10671.27% from $11.3 million recorded in Q3 2022.
  • Iterum Therapeutics' 5-year Change in Cash high stood at $51.9 million for Q1 2021, and its period low was -$45.3 million during Q3 2018.
  • Moreover, its 5-year median value for Change in Cash was -$24000.0 (2021), whereas its average is $632050.0.
  • Its Change in Cash has fluctuated over the past 5 years, first crashed by 58621.04% in 2019, then soared by 191642.51% in 2022.
  • Quarter analysis of 5 years shows Iterum Therapeutics' Change in Cash stood at $5.0 million in 2018, then crashed by 586.21% to -$24.1 million in 2019, then surged by 125.41% to $6.1 million in 2020, then plummeted by 239.48% to -$8.5 million in 2021, then surged by 106.71% to $573000.0 in 2022.
  • Its Change in Cash was $573000.0 in Q4 2022, compared to $11.3 million in Q3 2022 and -$22.2 million in Q2 2022.